Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Pal

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Carbohydrate Polymers|July 20, 2019
Aquasorbent guargum grafted hyperbranched poly (acrylic acid): A potential culture medium for microbes and plant tissuesTamalika Das, Srijoni Sengupta, Abhijit Pal, et al.
Anticancer Research|April 27, 2024
Comparison of Prognostic Scores in Early Phase Clinical Trials: A 10-year Single Centre Australian ExperienceSarah Childs, Udit Nindra, Robert Yoon, et al.
Molecules (Basel, Switzerland)|February 2, 2021
Morphology and Physico-Mechanical Threshold of α-Cellulose as Filler in an E-SBR CompositeSoumya Ghosh Chowdhury, Jagannath Chanda, Sreedip Ghosh, et al.
Oncology|September 12, 2024
Social Characteristics of Culturally and Linguistically Diverse Cancer Patients Enrolled in Early Phase Clinical Trials in South Western SydneySarah Childs, Udit Nindra, Gowri Shivasabesan, et al.
Journal of Paediatrics and Child Health|August 26, 2009
The epidemiology of health conditions of newly arrived refugee children: a review of patients attending a specialist health clinic in SydneyMohamud Sheikh, Abhijit Pal, Shu Wang, et al.
Thoracic Cancer|September 16, 2022
Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumabUdit Nindra, Adel Shahnam, Samuel Stevens, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2023
Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumabUdit Nindra, Adel Shahnam, Samuel Stevens, et al.
Cancers|November 27, 2025
Documentation of Advance Care Planning in Early Phase Cancer Clinical Trials: An Australian Single-Centre ExperienceNancy Huang, Joseph Descallar, Samuel Vo, et al.
JNCI Cancer Spectrum|March 28, 2025
Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort studyUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
BMJ Open|September 7, 2021
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)Abhijit Pal, Sarah Stapleton, Christina Yap, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Carbohydrate Polymers|July 20, 2019
Aquasorbent guargum grafted hyperbranched poly (acrylic acid): A potential culture medium for microbes and plant tissuesTamalika Das, Srijoni Sengupta, Abhijit Pal, et al.
Anticancer Research|April 27, 2024
Comparison of Prognostic Scores in Early Phase Clinical Trials: A 10-year Single Centre Australian ExperienceSarah Childs, Udit Nindra, Robert Yoon, et al.
Molecules (Basel, Switzerland)|February 2, 2021
Morphology and Physico-Mechanical Threshold of α-Cellulose as Filler in an E-SBR CompositeSoumya Ghosh Chowdhury, Jagannath Chanda, Sreedip Ghosh, et al.
Oncology|September 12, 2024
Social Characteristics of Culturally and Linguistically Diverse Cancer Patients Enrolled in Early Phase Clinical Trials in South Western SydneySarah Childs, Udit Nindra, Gowri Shivasabesan, et al.
Journal of Paediatrics and Child Health|August 26, 2009
The epidemiology of health conditions of newly arrived refugee children: a review of patients attending a specialist health clinic in SydneyMohamud Sheikh, Abhijit Pal, Shu Wang, et al.
Thoracic Cancer|September 16, 2022
Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumabUdit Nindra, Adel Shahnam, Samuel Stevens, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2023
Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumabUdit Nindra, Adel Shahnam, Samuel Stevens, et al.
Cancers|November 27, 2025
Documentation of Advance Care Planning in Early Phase Cancer Clinical Trials: An Australian Single-Centre ExperienceNancy Huang, Joseph Descallar, Samuel Vo, et al.
JNCI Cancer Spectrum|March 28, 2025
Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort studyUdit Nindra, Joanne Tang, Jun Hee Hong, et al.
BMJ Open|September 7, 2021
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)Abhijit Pal, Sarah Stapleton, Christina Yap, et al.
Pageof 5